Achieving a safe and early discharge for patients with community-acquired pneumonia.
The rationale for achieving an early discharge for patients with CAP is that reduced length of stay can result in lower costs. When hospital discharge is premature, however, use of resources after discharge from the hospital may increase. This situation could increase overall cost and worsen quality of care. The objective should be to achieve a safe and early discharge. Several studies have evaluated methods for achieving this goal. Key findings from these studies are as follows: When a patient achieves clinical stability (e.g., systolic blood pressure, > or = 90 mm Hg; heart rate, < or = 100 beats/min; respiratory rate, < or = 24 breaths/min; temperature, < or = 38.3 degrees C [101 degrees F]; oxygen saturation, > or = 90%; able to eat; and stable mental status) or fulfills appropriate criteria (see Table 2), the patient may be eligible for switch from parenteral to oral antibiotics and early discharge. For many patients, this switch or discharge may occur on day 3 of hospitalization. When a patient is switched from parenteral to oral antibiotics, in many cases there does not appear to be a demonstrable clinical benefit to in-hospital observation. Elimination of in-hospital observation for patients who do not have an obvious reason for continued hospitalization potentially could reduce length of stay by 1 day. Improving efficiency of care reduces length of stay. This reduction may be accomplished by implementing clinical pathways, identifying and correcting causes of medically unnecessary hospital days, initiating early discharge planning, enlisting the services of a discharge coordinator, and organizing outpatient parenteral antibiotic treatment programs. These strategies are effective in many but not all patients, and their application should be tempered with careful clinical judgment.
Rhew
D C
DC
Division of Infectious Diseases, Greater Los Angeles Veterans Affairs Healthcare System, University of California Los Angeles School of Medicine, Zynx Health Incorporated, a subsidiary of Cedars-Sinai Health System, USA. rhew@zynx.com
Weingarten
S R
SR
D000367:Age Factors; D000368:Aged; D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy*; D019091:Critical Pathways / Q000458:organization & administration; D017598:Efficiency, Organizational; D006801:Humans; D007902:Length of Stay / Q000191:economics / Q000706:statistics & numerical data; D010043:Outcome and Process Assessment, Health Care / Q000458:organization & administration; D010351:Patient Discharge / Q000191:economics / Q000592:standards* / Q000706:statistics & numerical data; D018579:Patient Selection; D011014:Pneumonia / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy*; D011787:Quality of Health Care; D012449:Safety; D013997:Time Factors; D017749:Total Quality Management / Q000458:organization & administration; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents